Showing results (2071-2080 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|May 18, 2005
Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsyLucie Blais, Odile Sheehy, Jean-Marc St-Hilaire, et al.Pharmacoeconomics|May 18, 2005
Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapyErnst Berndt, Joel Kallich, Anne McDermott, et al.Pharmacoeconomics|September 29, 2004
Cost effectiveness of ramipril in patients at high risk for cardiovascular events : economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for Germany from the Statutory Health Insurance perspectivePeter K Schädlich, Josef Georg Brecht, Badrudin Rangoonwala, et al.Pharmacoeconomics|August 27, 2004
A decision chart for assessing and improving the transferability of economic evaluation results between countriesRobert Welte, Talitha Feenstra, Hans Jager, et al.Pharmacoeconomics|August 16, 2005
Real-world trials to answer real-world questionsNick Freemantle, Lawrence Blonde, Bjorn Bolinder, et al.Pharmacoeconomics|August 16, 2005
Pharmaceutical policy regarding generic drugs in BelgiumSteven Simoens, Kristien De Bruyn, Marc Bogaert, et al.Pharmacoeconomics|April 20, 2005
The relationship between productivity and health-related QOL: an explorationWerner B F Brouwer, Willem-Jan Meerding, Leida M Lamers, et al.Pharmacoeconomics|April 20, 2005
Penny and pound wise: pharmacoeconomics from a governmental perspectiveMike F van Oostenbruggen, Ronald B Jansen, Katja Mur, et al.Pharmacoeconomics|April 20, 2005
The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysisJan Sørensen, Lis S AndersenPharmacoeconomics|April 28, 2005
Future challenges for the economic evaluation of healthcare: patient preferences, risk attitudes and beyondJohn F P BridgesPageof 336